Recombinant Enolase of Trypanosoma cruzi as a Novel Vaccine Candidate against Chagas Disease in a Mouse Model of Acute Infection
Trypanosoma cruzi is the protozoan parasite that causes Chagas disease, which is considered by the World Health Organization to be a neglected tropical disease. Two drugs exist for the treatment of Chagas disease, nifurtimox and benznidazole; they are only effective in the acute phase, and a vaccine...
Saved in:
Main Authors: | Minerva Arce-Fonseca, María Cristina González-Vázquez, Olivia Rodríguez-Morales, Verónica Graullera-Rivera, Alberto Aranda-Fraustro, Pedro A. Reyes, Alejandro Carabarin-Lima, José Luis Rosales-Encina |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2018/8964085 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of PPARs in Trypanosoma cruzi Infection: Implications for Chagas Disease Therapy
by: Eugenia Hovsepian, et al.
Published: (2012-01-01) -
Immune Evasion Strategies of Trypanosoma cruzi
by: Ana Flávia Nardy, et al.
Published: (2015-01-01) -
Alternative transmission modes for Trypanosoma cruzi
by: Christopher M. Kribs-Zaleta
Published: (2010-05-01) -
Trypanosoma cruzi Infection and Host Lipid Metabolism
by: Qianqian Miao, et al.
Published: (2014-01-01) -
Lysophosphatidylcholine: A Novel Modulator of Trypanosoma cruzi Transmission
by: Mário A. C. Silva-Neto, et al.
Published: (2012-01-01)